Back to News
Oct 6, 2025 4:20 PM

Eli Lilly Eyes India For Manufacturing, Plans To Spend $1 Billion

Eli Lilly and Co. (NASDAQ:LLY) plans to invest over $1 billion in India to strengthen its manufacturing network, according to Reuters.

The move aims to tap into the country's skilled workforce and support Lilly's global expansion.

The collaborations are designed to increase the availability of key treatments for obesity, diabetes, Alzheimer's disease, cancer, and autoimmune conditions.

Currently, Lilly does not operate its own manufacturing facility in India. Instead, it plans to collaborate contractually with local firms that produce complex drugs, vials, and injectables.

Also Read: Novo’s India ...